Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabinoids and Biological Reactivity to Stress
NCT06430580Phase 1Completed
- Sponsor
- Florida State University
- Start
- Sep 2024
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of hydrocortisone and yohimbine (4 arms), sponsored by Florida State University. Primary endpoints: Amplitude of neurophysiological response to cannabis cues, Amplitude of Demand Intensity for Cannabis and 5 more. Started Sep 2024; status: completed.
02
Drugs
hydrocortisoneyohimbine
Beyond the preview
Go deeper on NCT06430580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06430580.